Is Sensory Modulation Disorder a Risk Factor for Female Sexual Dysfunction?

2021 ◽  
Vol 75 (Supplement_2) ◽  
pp. 7512510273p1-7512510273p1
Author(s):  
Aviva Yochman ◽  
Mijal Luria ◽  
Hadas Noy-Nota

Abstract Date Presented Accepted for AOTA INSPIRE 2021 but unable to be presented due to online event limitations. Individuals with female sexual dysfunction (FSD) were found to be at increased risk for sensory over-responsivity across sensory modalities. OTs provide services for a variety of diagnostic populations with sexual dysfunction and should expand their unique role to include individuals with co-occurring FSD and sensory modulation disorder, by incorporating sensory processing into the routine evaluation and providing sensory strategies to facilitate satisfying sexual functioning. Primary Author and Speaker: Aviva Yochman Contributing Authors: Mijal Luria, Hadas Noy-Nota

CNS Spectrums ◽  
2003 ◽  
Vol 8 (3) ◽  
pp. 188-193 ◽  
Author(s):  
Julia K. Warnock ◽  
C. Faye Biggs

AbstractAre reproductive life events in women associated with an increased risk of sexual dysfunction? Female sexual dysfunction effects up to 40% of women in the United States between 18 and 59 years of age. Sexual dysfunction may be accompanied by fluctuations in gonadal hormone secretion, making women more vulnerable to sexual symptoms, especially during times of reproductive life events. Reproductive life events, such as the use of birth control pills, various phases of the menstrual cycles, postpartum and lactation states, and perimenopause, are highly correlated with changes in sex steroids. As an understanding of the role of sex steroids on sexual functioning is elucidated, clinicians will be able to offer more specific and effective treatment options for women during various phases of reproductive life. Several case studies are presented to illustrate the unique clinical considerations that a clinician must consider when treating the biologic component of female sexual dysfunction.


2021 ◽  
Vol 75 (Supplement_2) ◽  
pp. 7512505219p1-7512505219p1
Author(s):  
Aviva Yochman

Abstract Date Presented Accepted for AOTA INSPIRE 2021 but unable to be presented due to online event limitations. A comparison between children with and without posttraumatic stress (PTS) symptoms found that children with PTS symptoms are at increased risk for sensory processing deficits in various sensory modalities, over and above the core symptoms of posttraumatic stress disorder. These results emphasize that sensory processing should be incorporated into the routine evaluation of this population and point to the importance of OT trauma-informed intervention programs, emphasizing the sensory component of regulation. Primary Author and Speaker: Aviva Yochman


2016 ◽  
Vol 9 (1) ◽  
pp. 158-158
Author(s):  
M. Gómez-Lugo ◽  
◽  
P. Vallejo-Medina ◽  
J. P. Saffón ◽  
D. Saavedra-Roa ◽  
...  

Objective: Sexual dysfunction is an important public health concern. Sexual dysfunctions, characterized by disturbances in sexual desire, arousal, erection, orgasm or sexual satisfaction have been reported in different research around the world. Prevalence range of disturbances is from 20% to 30% and 40% to 45% for men and women respectively. The aim of this study was to explore prevalence of sexual dysfunction in a Colombian male and female sample. Design and Method: Sample was composed by a non-representative national sample of 1366 women and 1410 men, aged from 18 to 73. To assess sexual dysfunction the Colombian version of the Massachusetts General Hospital- Sexual Functioning Questionnaire (MGH-SFQ) was used. Results: Results indicate on one hand that sexual dysfunction is more prevalent in women (42.5%) than men (32.1 %). On the other hand, in women, problems related to desire (28.5%) were more common, while in men those related to desire and sexual satisfaction, 21.4% and 21% respectively, were more prevalent. In women, problems related to desire (28.5%) were more common, while in men those related to desire and sexual satisfaction 21.4% and 21%, respectively were more prevalent. Furthermore, no evidence was found about the relationship between the sociodemographic characteristic (socioeconomic level, years of education and religion) and the sexual dysfunction; with exception of age. These results are similar to those observed in other cultures. Conclusions: This study shows the importance of epidemiologic research in male and female sexual dysfunction for the identification of risk factors.


2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
R. Balon

The first challenge in diagnosing female sexual dysfunction(s) originates in our diagnostic system. The traditional model of classifying sexual dysfunction is anchored in the sexual response cycle: desire - arousal - orgasm - resolution. However, as some experts have pointed out, this classification may be problematic in the area of female sexuality. Both the diagnoses of female hypoactive sexual desire disorder (FHSDD) and female arousal disorder (FSAD) probably need to be redefined and refined. Examples include adding the lack of responsive desire to the FHSDD criteria and creating categories of subjective FSAD and genital FSAD.The second challenge in diagnosis female dysfunction is the lack of solid diagnostic instruments, diagnosis-specific laboratory assays and other specific testing. Specific measures of female sexual functioning, such as Female Sexual Functioning Index, Profile of Female Sexual Functioning, Sexual Function Questionnaire, Sexual Desire and Interest Inventory, and Female Sexual Distress Scale were mostly developed as outcome measures. No solid diagnostic instrument for sexual dysfunction exists, not even a version of the Structured Clinical Interview for DSM sexual dysfunctions. The contribution of imaging techniques, such as ultrasonography, magnetic resonance imaging or thermography, to the diagnosis is unclear, and these techniques are far (if ever) from clinical use.Thus, a detailed comprehensive clinical interview combined with physical examination, possibly a gynecological examination, and in some cases laboratory hormonal testing remains the cornerstone of diagnosing and assessing female sexual dysfunctions.


2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Felix Mwembi Oindi ◽  
Alfred Murage ◽  
Valentino Manase Lema ◽  
Abraham Mwaniki Mukaindo

Abstract Background Sexual function plays an essential role in the bio-psychosocial wellbeing and quality of life of women and disturbances in sexual functioning often result in significant distress. Female sexual dysfunction (FSD) and subfertility are common problems affecting approximately 43 and 20% of women respectively. However, despite the high prevalence of both conditions, little has been studied on the effects of subfertility on sexual functioning especially in sub-Saharan Africa. We set out to compare the prevalence of female sexual dysfunction in patients on assessment for sub-fertility and those either seeking or already on fertility control services at a private tertiary teaching hospital in Kenya. Methods This was an analytical cross sectional study. Eligible women of reproductive age (18–49 years), attending the gynaecological clinics with complaints of subfertility and those seeking fertility control services were requested to fill a general demographic tool containing personal data and the Female Sexual Function Index (FSFI) questionnaire after informed consent. Prevalence of sexual dysfunction was calculated as a percentage of patients not achieving an overall FSFI score of 26.55. Univariate and multivariate analysis were done to compare clinical variables to delineate the potential association. Results The prevalence of female sexual dysfunction was 31.2% in the subfertile group and 22.6% in fertility control group. The difference was not statistically significant (p = 0.187). The mean domain and overall female sexual function scores were lower in the subfertile group than the fertility control group though this was not statistically significant. The most prevalent sexual domain dysfunctions in both the subfertility and fertility control groups were desire and arousal while the least in both groups was satisfaction dysfunction. Subfertility type was not associated with sexual dysfunction. Higher education attainment was protective of female sexual dysfunction in the subfertile group while use of hormonal contraception was associated with greater sexual impairment in the fertility control group. On logistic regression analysis, higher maternal age and alcohol use appeared to be protective against sexual dysfunction. Conclusion The present study demonstrated no association between the fertility status and the prevalence female sexual dysfunction. Subfertility type was not associated with sexual dysfunction. Education level and hormonal contraception use were associated with female sexual dysfunction in the subfertile and fertility control groups respectively while alcohol use and higher maternal age appeared to be protective against sexual dysfunction.


GYNECOLOGY ◽  
2021 ◽  
Vol 23 (2) ◽  
pp. 149-154
Author(s):  
Natalia N. Stenyaeva ◽  
Dmitrii F. Chritinin ◽  
Andrei A. Chausov

Background. Female sexual dysfunction is extremely common and affects about half of the worlds women. Currently, the question of the relationship between gynecological morbidity in women and the characteristics of sexual activity and sexual functioning in a couple remains poorly understood. Aim. To establish gynecological diseases associated with decreased sexual functioning, sexual health disorders in women on the basis of a screening assessment when visiting the clinic. Materials and methods. We conducted a cross-sectional descriptive study of the sexual functioning of 1256 women who presented to outpatient appointments. Anamnestic and clinical methods were used, sexological testing using the Female Sexual Function Index questionnaire. Results. Based on anamnestic data, screening assessment of sexual health and sexual functioning of 1235 women who applied for outpatient appointments to a gynecological clinic, a high gynecological and extragenital morbidity was established in patients (100%). The structure of gynecological diseases is represented by female infertility (48.3%), inflammatory diseases of the genital organs (38.5%; of which salpingo-oophoritis 16.6% and vulvovaginitis 15.9%), endometriosis (13.9%) , menstrual irregularities (8.3%), as well as pain disorders (8.1%). The incidence of infections, predominantly sexually transmitted, was revealed, among them papillomatous viral infection (8.3%), genital herpes (5.3%) and chlamydia (3.7%). It was found that in gynecological patients with diseases characterized by a chronic course, inflammation, pelvic pain, menstrual and reproductive disorders, sexual functioning significantly decreases (p=0.00) and sexual health is impaired. Sexual dysfunctions were detected in 21.6% of patients, their structure is represented by isolated (39.3%) and combined (60.7%) disorders of libido, orgasm, sexual anhedonia, failure of genital response, as well as dyspareunia, vaginismus. In 33.7% of patients, preclinical forms of sexual dysfunction were identified that did not meet the criteria for sexual dysfunction (did not cause distress, were short-lived), but confirmed by the analysis of patient complaints, as well as by the results of the Female Sexual Function Index questionnaire. Conclusion. Thus, chronic gynecological diseases with inflammatory manifestations, pelvic pain, menstrual and reproductive dysfunctions are associated with decreased sexual functioning, sexual dysfunctions, and preclinical forms of sexual dysfunctions.


2015 ◽  
Vol 48 (5) ◽  
pp. 478
Author(s):  
Alessandra B. Trovó de Marqui ◽  
Maria Paula C. Silva ◽  
Gabriela R. F. Irie

Este estudo teve como objetivo avaliar a função sexual das pacientes com endometriose, bem como a participação de fatores de risco. Foi realizada uma pesquisa bibliográfica no PubMed, em março de 2014, empregando os seguintes descritores: quality of sex life and endometriosis, sexual life and endometriosis, female sexual dysfunction and endometriosis e sexual functioning and endometriosis. Foram encontrados 152 artigos e de acordo com os critérios de inclusão e exclusão previamente estabelecidos, 20 foram selecionados. Treze estudos investigaram a contribuição do tratamento na disfunção sexual feminina. Ansiedade e depressão são fatores que também influenciam a função sexual, mas foram investigadas em apenas três estudos. As pacientes com endometriose exibem comprometimento da função sexual e, portanto, a investigação sobre sua vida sexual deve ser averiguada, tendo em vista os prejuízos causados pela disfunção na qualidade de vida das mulheres.


Sign in / Sign up

Export Citation Format

Share Document